Shanghai Jinshan Pharmaceutical

Shanghai Jinshan Pharmaceutical Co., Ltd. is a prominent manufacturing subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH), specializing in the development and production of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. Established in 1970 and based in the Jinshan District of Shanghai, the company focuses on small molecule therapeutics for psychiatric, cardiovascular, and endocrine conditions. Its product portfolio includes widely used medications such as Sertraline Hydrochloride, Furosemide, and Acetazolamide. In addition to its proprietary product line, the company provides comprehensive contract manufacturing (CDMO) services and is a leading producer of fine chemicals and phosphonium compounds. Shanghai Jinshan Pharmaceutical operates state-of-the-art, GMP-compliant facilities and serves as a critical industrial base for SPH's global supply chain.